Insider · CIK 0001314760
William P Forbes
directorofficer
Files at HRTX (HERON THERAPEUTICS, INC. /DE/), XAIR (Beyond Air, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +11,695 | - | - | 181,773 | Feb 3, 2026 |
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Restricted Stock Unitsderivative | +188,315 | $0.00 | $0 | 188,315 | Feb 3, 2026 |
| Jan 31, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -11,695 | $0.00 | $0 | 140,332 | Feb 3, 2026 |
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Performance Stock Unitsderivative | +188,314 | $0.00 | $0 | 188,314 | Feb 3, 2026 |
| Jan 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +3,875 | - | - | 170,078 | Jan 20, 2026 |
| Jan 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -3,875 | $0.00 | $0 | 30,994 | Jan 20, 2026 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -400 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +400 | - | - | 400 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -1,500 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,500 | - | - | 1,500 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -2,000 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +2,000 | - | - | 2,000 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -2,250 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +2,250 | - | - | 2,250 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -3,750 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +3,750 | - | - | 3,750 | Nov 6, 2025 |
| Oct 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +11,694 | - | - | 166,203 | Nov 4, 2025 |
| Oct 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -11,694 | $0.00 | $0 | 152,027 | Nov 4, 2025 |
| Oct 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +3,874 | - | - | 154,509 | Oct 21, 2025 |
| Oct 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -3,874 | $0.00 | $0 | 34,869 | Oct 21, 2025 |
| Jul 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +11,695 | - | - | 150,635 | Aug 4, 2025 |
| Jul 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -11,695 | $0.00 | $0 | 163,721 | Aug 4, 2025 |
| Jul 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +3,874 | - | - | 138,940 | Jul 22, 2025 |
| Jul 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -3,874 | $0.00 | $0 | 38,743 | Jul 22, 2025 |
| Jun 6, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +12,500 | - | - | 135,066 | Jun 9, 2025 |
| Jun 6, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -12,500 | $0.00 | $0 | 25,000 | Jun 9, 2025 |
| Apr 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +11,694 | - | - | 122,566 | May 2, 2025 |
| Apr 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -11,694 | $0.00 | $0 | 175,416 | May 2, 2025 |
| Apr 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +3,875 | - | - | 110,872 | Apr 22, 2025 |
| Apr 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -3,875 | $0.00 | $0 | 42,617 | Apr 22, 2025 |
| Mar 26, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Mar 28, 2025 |
| Jan 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Employee Stock Option (Right to Buy)derivative | +374,220 | $0.00 | $0 | 374,220 | Feb 4, 2025 |
| Jan 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Restricted Stock Unitsderivative | +187,110 | $0.00 | $0 | 187,110 | Feb 4, 2025 |
| Jan 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +3,874 | - | - | 106,997 | Jan 22, 2025 |
| Jan 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -3,874 | $0.00 | $0 | 46,492 | Jan 22, 2025 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -25,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +25,000 | - | - | 25,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -8,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +8,000 | - | - | 8,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -25,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +25,000 | - | - | 25,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -25,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +25,000 | - | - | 25,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -30,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +30,000 | - | - | 30,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -40,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +40,000 | - | - | 40,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -45,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +45,000 | - | - | 45,000 | Nov 26, 2024 |
| Oct 19, 2024 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +3,874 | - | - | 103,123 | Oct 21, 2024 |
| Oct 19, 2024 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -3,874 | $0.00 | $0 | 50,366 | Oct 21, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.